Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital

American Journal of Hematology

Volumn 82, Issue 12, 2007, Pages 1091-1094

  Ozgonenel, Bulent ^a   O'Malley, Barbara ^a   Krishen, Priya ^a   Eisenbrey, A B ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD BANK; BLOOD CLOTTING DISORDER; CHILD; CONTROLLED STUDY; DRUG HALF LIFE; DRUG USE; ELDERLY CARE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PATIENT MONITORING; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TREATMENT INDICATION;

ANTICOAGULANTS; BLOOD COAGULATION; HEMORRHAGE; HUMANS; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; WARFARIN;

EID: 36749087522     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20902     Document Type: Article

References (27)

1. Deitcher SR, Rodgers GM. Thrombosis and antithrombotic therapy. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, editors. Wintrobe's Clinical Hematology. Philadelphia: Lippincott Williams and Wilkins; 2004. pp 1713-1758.
2. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM. Warfarin reversal: Consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004;181:492-427.
3. Hanley JP. Warfarin reversal. J Clin Pathol 2004;57:1132-1139.
4. Spence RK. Clinical use of plasma and plasma fractions. Best Pract Res Clin Haematol 2006;19:83-96.
5. Hui CH, Williams I, Davis K. Clinical audit of the use of fresh-frozen plasma and platelets in a tertiary teaching hospital and the impact of a new transfusion request form. Intern Med J 2005;35:283-288.
6. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3, Suppl):204S-233S.
7. Horton JD, Bushwick BM. Warfarin therapy: Evolving strategies in anticoagulation. Am Fam Physician 1999;59:635-646.
8. Ozawa H, Abiko Y, Akimoto T. [A 50-year history of new drugs in Japan - The development and trends of hemostatics and antithrombotic drugs]. Yakushigaku Zasshi 2003;38:93-105.
9. Nilsson GH, Bjorholt I, Krakau I. Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden - A retrospective study of incidence and quality in a registered population. Fam Pract 2004;21:612-616.
10. Stein PD, Hull RD, Kayali F, Ghali WA, Alshab AK, Olson RE. Venous thromboembolism according to age: The impact of an aging population. Arch Intern Med 2004;164:2260-2265.
11. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998;352:1167-1171.
12. Fang MC, Chang Y, Hylek EM, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004;141:745-752.
13. Ivascu FA, Howells GA, Junn FS, Bair HA, Bendick PJ, Janczyk RJ. Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality. J Trauma 2005;59:1131-1137; Discussion 1137-1139.
14. Goldstein JN, Thomas SH, Frontiero V, et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 2006;37:151-155.
15. Powner DJ, Hartwell EA, Hoots WK. Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery 2005;57:823-831; Discussion 823-831.
16. MacLennan S, Barbara JA. Risks and side effects of therapy with plasma and plasma fractions. Best Pract Res Clin Haematol 2006;19:169-189.
17. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004;126:11-28.
18. Hemphill JC III. Treating warfarin-related intracerebral hemorrhage: Is fresh frozen plasma enough? Stroke 2006;37:6-7.
19. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 1992;23:972-977.
20. Alving BM. Transfusion of the patient with acquired coagulation defects. In: Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roush KS, editors. Blood Banking and Transfusion Medicine Basic Principles and Practice. Philadelphia: Churchill Livingstone; 2003. pp307-320.
21. Di Minno G, Tufano A, Cerbone AM. Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG). Nutr Metab Cardiovasc Dis 2001;11:41-62.
22. Shapiro SS. Treating thrombosis in the 21st century. N Engl J Med 2003;349:1762-1764.
23. Kagansky N, Knobler H, Rimon E, Ozer Z, Levy S. Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med 2004;164:2044-2050.
24. Sorensen B, Johansen P, Nielsen GL, Sorensen JC, Ingerslev J. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: Clinical and biochemical aspects. Blood Coagul Fibrinolysis 2003;14:469-477.
25. Veshchev I, Elran H, Salame K. Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma. Med Sci Monit 2002;8:CS98-CS100.
26. Chaudhary R, Singh H, Verma A, Ray V. Evaluation of fresh frozen plasma usage at a tertiary care hospital in North India. ANZ J Surg 2005;75:573-576.
27. Chng WJ, Tan MK, Kuperan P. An audit of fresh frozen plasma usage in an acute general hospital in Singapore. Singapore Med J 2003;44:574-578.